Our MS experimental conditions did not allow identification of either TS and DHFR, as they are difficult to detect in differential proteomic experiments on tissue cancer samples due to their nuclear compartmentalization and low physiological concentrations, despite their recognized relevant role in cancer and drug resistance [62,63]. The gene discussed is TYMS; the disease is cancer.